Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001415889-14-000926
Filing Date
2014-03-25
Accepted
2014-03-24 17:54:45
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K fluoropharma10k_dec312013.htm 10-K 1819177
2 ex10-14.htm EX-10.14 50772
3 CONSENT OF WOLF & COMPANY, P.C. ex23-1.htm EX-23.1 2605
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 OF THE SECURITI ex31-1.htm EX-31.1 9730
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14 OF THE SECURITI ex31-2.htm EX-31.2 10435
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 1350. ex32-1.htm EX-32.1 4923
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 1350. ex32-2.htm EX-32.2 5184
  Complete submission text file 0001415889-14-000926.txt   6787854

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT fpmi-20131231.xml EX-101.INS 687625
9 XBRL TAXONOMY EXTENSION SCHEMA fpmi-20131231.xsd EX-101.SCH 80689
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fpmi-20131231_cal.xml EX-101.CAL 50293
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fpmi-20131231_def.xml EX-101.DEF 153437
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE fpmi-20131231_lab.xml EX-101.LAB 444900
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fpmi-20131231_pre.xml EX-101.PRE 314854
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

EIN.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-147193 | Film No.: 14714088
SIC: 2835 In Vitro & In Vivo Diagnostic Substances